Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 1/2013

01-07-2013 | Review Article

Challenges in accurate registration of 3-D medical imaging and histopathology in primary prostate cancer

Authors: Charles Meyer, Bing Ma, Lakshmi P. Kunju, Matthew Davenport, Morand Piert

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Special Issue 1/2013

Login to get access

Abstract

Due to poor correlation between slice thickness and orientation, verification of medical imaging results by histology is difficult. Often validation of imaging findings of lesions suspicious for prostate cancer is driven by a subjective, visual approach to correlate in vivo images with histopathology. We describe fallacious assumptions in the correlation of imaging findings with pathology and identify the lack of accurate registration as a major obstacle in the validation of PET and PET/CT imaging in primary prostate cancer. Specific registration techniques that facilitate the most difficult part of the registration process—the mapping of pathology onto high-resolution imaging, preferably aided by the ex vivo prostate specimen—are discussed.
Literature
1.
go back to reference American Cancer Society. Cancer facts and figures 2012. Atlanta: American Cancer Society; 2012 American Cancer Society. Cancer facts and figures 2012. Atlanta: American Cancer Society; 2012
2.
go back to reference Bill-Axelson A, Holmberg L, Filen F, Ruutu M, Garmo H, Busch C, et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst. 2008;100:1144–54.PubMedCrossRef Bill-Axelson A, Holmberg L, Filen F, Ruutu M, Garmo H, Busch C, et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst. 2008;100:1144–54.PubMedCrossRef
3.
go back to reference Epstein JI, Chan DW, Sokoll LJ, Walsh PC, Cox JL, Rittenhouse H, et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol. 1998;160:2407–11.PubMedCrossRef Epstein JI, Chan DW, Sokoll LJ, Walsh PC, Cox JL, Rittenhouse H, et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol. 1998;160:2407–11.PubMedCrossRef
4.
go back to reference Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994;271:368–74.PubMedCrossRef Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994;271:368–74.PubMedCrossRef
5.
go back to reference Karavitakis M, Ahmed HU, Abel PD, Hazell S, Winkler MH. Tumor focality in prostate cancer: implications for focal therapy. Nat Rev Clin Oncol. 2011;8:48–55.PubMedCrossRef Karavitakis M, Ahmed HU, Abel PD, Hazell S, Winkler MH. Tumor focality in prostate cancer: implications for focal therapy. Nat Rev Clin Oncol. 2011;8:48–55.PubMedCrossRef
6.
go back to reference Farsad M, Schwarzenbock S, Krause BJ. PET/CT and choline: diagnosis and staging. Q J Nucl Med Mol Imaging. 2012;56:343–53.PubMed Farsad M, Schwarzenbock S, Krause BJ. PET/CT and choline: diagnosis and staging. Q J Nucl Med Mol Imaging. 2012;56:343–53.PubMed
7.
go back to reference Li X, Liu Q, Wang M, Jin X, Yao S, Liu S, et al. C-11 choline PET/CT imaging for differentiating malignant from benign prostate lesions. Clin Nucl Med. 2008;33:671–6.PubMedCrossRef Li X, Liu Q, Wang M, Jin X, Yao S, Liu S, et al. C-11 choline PET/CT imaging for differentiating malignant from benign prostate lesions. Clin Nucl Med. 2008;33:671–6.PubMedCrossRef
8.
go back to reference Piert M, Park H, Khan A, Siddiqui J, Hussain H, Chenevert T, et al. Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques. J Nucl Med. 2009;50:1585–93.PubMedCrossRef Piert M, Park H, Khan A, Siddiqui J, Hussain H, Chenevert T, et al. Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques. J Nucl Med. 2009;50:1585–93.PubMedCrossRef
9.
go back to reference Chen J, Zhao Y, Li X, Sun P, Wang M, Wang R, et al. Imaging primary prostate cancer with 11C-choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness. Radiol Oncol. 2012;46:179–88.PubMedCrossRef Chen J, Zhao Y, Li X, Sun P, Wang M, Wang R, et al. Imaging primary prostate cancer with 11C-choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness. Radiol Oncol. 2012;46:179–88.PubMedCrossRef
10.
go back to reference Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, et al. 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med. 2012;53:538–45.PubMedCrossRef Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, et al. 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med. 2012;53:538–45.PubMedCrossRef
11.
go back to reference Cohen MS, Hanley RS, Kurteva T, Ruthazer R, Silverman ML, Sorcini A, et al. Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis. Eur Urol. 2008;54:371–81.PubMedCrossRef Cohen MS, Hanley RS, Kurteva T, Ruthazer R, Silverman ML, Sorcini A, et al. Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis. Eur Urol. 2008;54:371–81.PubMedCrossRef
12.
go back to reference Orczyk C, Mikheev A, Rosenkrantz A, Melamed J, Taneja SS, Rusinek H. Imaging of prostate cancer: A platform for 3D co-registration of in-vivo MRI ex-vivo MRI and pathology. Proc SPIE. 2012;8316:83162M Orczyk C, Mikheev A, Rosenkrantz A, Melamed J, Taneja SS, Rusinek H. Imaging of prostate cancer: A platform for 3D co-registration of in-vivo MRI ex-vivo MRI and pathology. Proc SPIE. 2012;8316:83162M
13.
go back to reference Jonmarker S, Valdman A, Lindberg A, Hellstrom M, Egevad L. Tissue shrinkage after fixation with formalin injection of prostatectomy specimens. Virchows Arch. 2006;449:297–301.PubMedCrossRef Jonmarker S, Valdman A, Lindberg A, Hellstrom M, Egevad L. Tissue shrinkage after fixation with formalin injection of prostatectomy specimens. Virchows Arch. 2006;449:297–301.PubMedCrossRef
14.
go back to reference Schned AR, Wheeler KJ, Hodorowski CA, Heaney JA, Ernstoff MS, Amdur RJ, et al. Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol. 1996;20:1501–6.PubMedCrossRef Schned AR, Wheeler KJ, Hodorowski CA, Heaney JA, Ernstoff MS, Amdur RJ, et al. Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol. 1996;20:1501–6.PubMedCrossRef
15.
go back to reference Kim B, Boes JL, Frey KA, Meyer CR. Mutual information for automated unwarping of rat brain autoradiographs. Neuroimage. 1997;5:31–40.PubMedCrossRef Kim B, Boes JL, Frey KA, Meyer CR. Mutual information for automated unwarping of rat brain autoradiographs. Neuroimage. 1997;5:31–40.PubMedCrossRef
16.
go back to reference Balter JM, Sandler HM, Lam K, Bree RL, Lichter AS, Ten Haken RK. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys. 1995;31:113–8.PubMedCrossRef Balter JM, Sandler HM, Lam K, Bree RL, Lichter AS, Ten Haken RK. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys. 1995;31:113–8.PubMedCrossRef
17.
go back to reference Dinkel J, Thieke C, Plathow C, Zamecnik P, Prum H, Huber PE, et al. Respiratory-induced prostate motion: characterization and quantification in dynamic MRI. Strahlenther Onkol. 2011;187:426–32.PubMedCrossRef Dinkel J, Thieke C, Plathow C, Zamecnik P, Prum H, Huber PE, et al. Respiratory-induced prostate motion: characterization and quantification in dynamic MRI. Strahlenther Onkol. 2011;187:426–32.PubMedCrossRef
18.
go back to reference Malone S, Crook JM, Kendal WS, Szanto J. Respiratory-induced prostate motion: quantification and characterization. Int J Radiat Oncol Biol Phys. 2000;48:105–9.PubMedCrossRef Malone S, Crook JM, Kendal WS, Szanto J. Respiratory-induced prostate motion: quantification and characterization. Int J Radiat Oncol Biol Phys. 2000;48:105–9.PubMedCrossRef
19.
go back to reference Udrescu C, Jalade P, de Bari B, Michel-Amadry G, Chapet O. Evaluation of the respiratory prostate motion with four-dimensional computed tomography scan acquisitions using three implanted markers. Radiother Oncol. 2012;103:266–9.PubMedCrossRef Udrescu C, Jalade P, de Bari B, Michel-Amadry G, Chapet O. Evaluation of the respiratory prostate motion with four-dimensional computed tomography scan acquisitions using three implanted markers. Radiother Oncol. 2012;103:266–9.PubMedCrossRef
20.
go back to reference Park H, Piert MR, Khan A, Shah R, Hussain H, Siddiqui J, et al. Registration methodology for histological sections and in vivo imaging of human prostate. Acad Radiol. 2008;15:1027–39.PubMedCrossRef Park H, Piert MR, Khan A, Shah R, Hussain H, Siddiqui J, et al. Registration methodology for histological sections and in vivo imaging of human prostate. Acad Radiol. 2008;15:1027–39.PubMedCrossRef
21.
go back to reference Zachariah CR, Pitt D, Wassenar P, Clymer BD, Abduljalil AM, Knopp MV, et al. Quantification of formalin-fixed MS brain tissue parameters T1, T2*, PD and phase at 7T and comparison with histopathology. Proceedings of the Annual Meeting of the International Society for Magnetic Resonance in Medicine; 2010 May 1–7; Stockholm, Sweden. Berkeley: International Society for Magnetic Resonance in Medicine; 2010. p. 2073. Zachariah CR, Pitt D, Wassenar P, Clymer BD, Abduljalil AM, Knopp MV, et al. Quantification of formalin-fixed MS brain tissue parameters T1, T2*, PD and phase at 7T and comparison with histopathology. Proceedings of the Annual Meeting of the International Society for Magnetic Resonance in Medicine; 2010 May 1–7; Stockholm, Sweden. Berkeley: International Society for Magnetic Resonance in Medicine; 2010. p. 2073.
22.
go back to reference Park H, Meyer CR, Wood D, Khan A, Shah R, Hussain H, et al. Validation of automatic target volume definition as demonstrated for 11C-choline PET/CT of human prostate cancer using multi-modality fusion techniques. Acad Radiol. 2010;17:614–23.PubMedCrossRef Park H, Meyer CR, Wood D, Khan A, Shah R, Hussain H, et al. Validation of automatic target volume definition as demonstrated for 11C-choline PET/CT of human prostate cancer using multi-modality fusion techniques. Acad Radiol. 2010;17:614–23.PubMedCrossRef
23.
go back to reference Park H, Wood D, Hussain H, Meyer CR, Shah RB, Johnson TD, et al. Introducing Parametric Fusion PET/MRI of Primary Prostate Cancer. J Nucl Med Mol Imaging. 2012;53:546–51. Park H, Wood D, Hussain H, Meyer CR, Shah RB, Johnson TD, et al. Introducing Parametric Fusion PET/MRI of Primary Prostate Cancer. J Nucl Med Mol Imaging. 2012;53:546–51.
24.
go back to reference Garcia-Parra R, Wood D, Shah R, Siddiqui J, Hussain H, Park H, et al. Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques. Eur J Nucl Med Mol Imaging. 2011;38:1816–23.PubMedCrossRef Garcia-Parra R, Wood D, Shah R, Siddiqui J, Hussain H, Park H, et al. Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques. Eur J Nucl Med Mol Imaging. 2011;38:1816–23.PubMedCrossRef
25.
go back to reference Drew B, Jones EC, Reinsberg S, Yung AC, Goldenberg SL, Kozlowski P. Device for sectioning prostatectomy specimens to facilitate comparison between histology and in vivo MRI. J Magn Reson Imaging. 2010;32:992–6.PubMedCrossRef Drew B, Jones EC, Reinsberg S, Yung AC, Goldenberg SL, Kozlowski P. Device for sectioning prostatectomy specimens to facilitate comparison between histology and in vivo MRI. J Magn Reson Imaging. 2010;32:992–6.PubMedCrossRef
26.
go back to reference Chen LH, Ho H, Lazaro R, Thng CH, Yuen J, Ng WS, et al. Optimum slicing of radical prostatectomy specimens for correlation between histopathology and medical images. Int J Comput Assist Radiol Surg. 2010;5:471–87.PubMedCrossRef Chen LH, Ho H, Lazaro R, Thng CH, Yuen J, Ng WS, et al. Optimum slicing of radical prostatectomy specimens for correlation between histopathology and medical images. Int J Comput Assist Radiol Surg. 2010;5:471–87.PubMedCrossRef
27.
go back to reference Shah V, Pohida T, Turkbey B, Mani H, Merino M, Pinto PA, et al. A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds. Rev Sci Instrum. 2009;80:104301.PubMedCrossRef Shah V, Pohida T, Turkbey B, Mani H, Merino M, Pinto PA, et al. A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds. Rev Sci Instrum. 2009;80:104301.PubMedCrossRef
28.
go back to reference Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, et al. Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology. 2012;79:233–9.PubMedCrossRef Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, et al. Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology. 2012;79:233–9.PubMedCrossRef
29.
go back to reference Fan X, Haney CR, Agrawal G, Pelizzari CA, Antic T, Eggener SE, et al. High-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: validation of a technique. J Magn Reson Imaging. 2011;34:956–61.PubMedCrossRef Fan X, Haney CR, Agrawal G, Pelizzari CA, Antic T, Eggener SE, et al. High-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: validation of a technique. J Magn Reson Imaging. 2011;34:956–61.PubMedCrossRef
30.
go back to reference Meyer CR, Wahl RL. Image fusion. In: Wahl RL, editor. Principle and practices of PET and PET/CT. 2nd ed. Philadelphia: Williams and Wilkins; 2009. p. 111–6. Meyer CR, Wahl RL. Image fusion. In: Wahl RL, editor. Principle and practices of PET and PET/CT. 2nd ed. Philadelphia: Williams and Wilkins; 2009. p. 111–6.
Metadata
Title
Challenges in accurate registration of 3-D medical imaging and histopathology in primary prostate cancer
Authors
Charles Meyer
Bing Ma
Lakshmi P. Kunju
Matthew Davenport
Morand Piert
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue Special Issue 1/2013
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-013-2382-2

Other articles of this Special Issue 1/2013

European Journal of Nuclear Medicine and Molecular Imaging 1/2013 Go to the issue